Related Experiment Video
Updated: Aug 26, 2025

Purification and Transplantation of Myogenic Progenitor Cell Derived Exosomes to Improve Cardiac Function in Duchenne Muscular Dystrophic Mice
Published on: April 10, 2019
Adipose-Derived Stem Cell Exosomes and Related microRNAs in Atherosclerotic Cardiovascular Disease
Fan Zhou1, Ke Li1, Keping Yang2
1Department of Cardiology, Jingzhou Hospital Affiliated to Yangtze University, Jingzhou, 434023, China.
Insights
Adipose-derived stem cell exosomes show promise in treating atherosclerotic cardiovascular disease (ASCVD). These exosomes impact macrophage polarization, endothelial function, and angiogenesis, offering new therapeutic avenues for ASCVD.
Area of Science:
- Biomedical research
- Cardiovascular science
- Regenerative medicine
Background:
- Atherosclerotic cardiovascular disease (ASCVD) is a major global health concern, leading to vascular occlusion and ischemic necrosis.
- Early prevention and treatment of atherosclerosis are crucial for managing ASCVD.
- Adipose-derived stem cells (ASCs) and their exosomes are emerging as significant players in cardiovascular disease research.
Purpose of the Study:
- To review the role of exosomes derived from adipose-derived stem cells (ASCs) in atherosclerotic cardiovascular disease (ASCVD).
- To explore the therapeutic potential of ASC-derived exosomes and their associated microRNAs in managing ASCVD.
Main Methods:
- Literature review focusing on studies investigating ASC-derived exosomes and their effects in cardiovascular disease models.
- Analysis of mechanisms including macrophage polarization, endothelial function, anti-apoptosis, and angiogenesis.
Main Results:
- ASC-derived exosomes demonstrate significant therapeutic effects in cardiovascular disease research.
- Key mechanisms involve modulating macrophage polarization, enhancing endothelial function, promoting anti-apoptosis, and stimulating angiogenesis.
- Specific microRNAs within these exosomes play a crucial role in ASCVD pathogenesis and treatment.
Conclusions:
- ASC-derived exosomes represent a promising cell-free therapeutic strategy for atherosclerotic cardiovascular disease.
- Targeting macrophage polarization, endothelial function, and angiogenesis via ASC exosomes offers novel treatment avenues.
- Further research into ASC-derived exosomes and their microRNAs is warranted for clinical translation in ASCVD management.
Abstract:
Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death from noncommunicable diseases worldwide. The pathological development of ASCVD begins with atherosclerosis, followed by the narrowing and occlusion of the vascular lumen and, subsequently, ischemic necrosis in coronary arteries. Preventing atherosclerosis development and delaying ischemia progression may be effective ways of pre-diagnosing and treating ASCVD. Studies have demonstrated that exosomes from adipose-derived stem cells play an increasingly important role in basic research on cardiovascular diseases in terms of the impact of macrophage polarization and the endothelial, anti-apoptosis, and angiogenesis effects. The related microRNAs play a significant role in ASCVD. This study was novel in reviewing the role of exosomes from adipose-derived stem cells and related microRNAs in ASCVD. Therapeutic potentials of adipose-derived stem cell exosomes in terms of their impact on macrophage polarization, endothelial effect, anti-apoptosis intervention, and angiogenesis.
More Related Videos
04:54Author Spotlight: Standardizing and Improving the Extraction and Purification of Extracellular Vesicles from Human ADSCs
Published on: May 3, 2024
06:56Author Spotlight: The Significance of Isolation, Culture, and Adipogenic Induction of SVF-Derived Preadipocytes from Mouse Perivascular Adipose Tissue
Published on: July 21, 2023
Related Concept Videos
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Inflammation
Mesenchymal Stem Cells
Atherosclerosis I: Introduction